Sorafenib in combination with chemotherapy as first-line therapy for FLT3-ITD positive acute myeloid leukemia

被引：0

作者：

张青玉 ^{[1
]}

机构：

[1] Instit Hematol & Blood Dis Hosp,CAMS & PUMC

来源：

China Medical Abstracts(Internal Medicine) | 2017年 / 34卷 / 03期

关键词：

FLT; ITD; Sorafenib in combination with chemotherapy as first-line therapy for FLT3-ITD positive acute myeloid leukemia;

D O I：

暂无

中图分类号：

R733.71 [急性白血病];

学科分类号：

100214 ;

摘要：

Objective To analyze the clinical features of acute myeloid leukemia patients with Fms-like tyrosine kinase3 interal tandem duplication(FLT3-ITD)mutation and the therapeutic effect of sorafenib in combination with chemotherapy as first-line therapy for these patients.Methods Clinical features and therapeutic effect were te-

引用

页码：182 / 182

页数：1